YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 38,525 followers.

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells https://t.co/4EWn1Ut6Bz

15 Feb 2024

Reply Repost Favourite

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells: Oncolytic viruses (OVs) selectively replicate in tumor cells resulting in lysis, spreading of new infectious…… #oncology https://t.co/Q0Wm2

04 Feb 2024

Reply Repost Favourite

RT @FrontOncology: New research: YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarc…

01 Feb 2024

Reply Repost Favourite

New research: YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells: Oncolytic viruses (OVs) selectively replicate in tumor cells resulting in lysis, spreading of new infectious… https://t.co/zK

01 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.